Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Histone Succinylation: A Predictive Biomarker for Malignant Solid Tumors

NCT07132606 is registered in ClinicalTrials.gov with Yinghua Ji as lead sponsor.

NCT NCT07132606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07132606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Histone Succinylation: A Predictive Biomarker for Malignant Solid Tumors
Lead sponsor
Yinghua Ji
Phase
Observational
Overall status
Not yet recruiting
Start date
August 20, 2025
Completion date
August 1, 2026
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumors